The Impact Investing Institute has appointed Kieron Boyle as its new chief executive officer.
Boyle will take up the role in May succeeding Sarah Gordon, who left the institute at the end of 2022.
Until Boyle officially takes up the position, senior institute executives Bella Landymore and Sarah Teacher will continue to serve as interim joint chief executives.
Boyle joins the institute following seven years as CEO of Guy’s & St Thomas’ Foundation, one of the world’s oldest foundations, and a pioneer in incorporating impact investment into the investment strategy of its £1bn endowment.
Boyle has a background in impact investing, having joined Guy’s & St Thomas’ from the Cabinet Office, where he was director of impact investment and the key architect, in 2012, of the UK Government’s strategy to make the UK a global hub for impact investing.
That work included the creation of Big Society Capital, the world’s first wholesale social investor, and putting impact investing on the agenda of the G8 during the UK’s presidency, in particular through the creation of the Social Impact Investment Taskforce.
Before joining the Cabinet Office, Boyle served in Number 10, the Department for Business, the Foreign and Commonwealth Office and the Prime Minister’s strategy unit. He started his career as a strategy consultant at the Boston Consulting Group in New York.
Dame Elizabeth Corley, chair of the Impact Investing Institute, said: “Kieron brings a long and exemplary record of advocacy, innovation and achievement in the area of impact investing. He is ideally skilled to realise the institute’s aspirations and take its accomplishments to the next level building on Sarah Gordon’s exceptional legacy as founding CEO.”
Boyle added: “Having spent over a decade in the field of impact investing, I am incredibly excited to lead the institute at such an important time. The world faces intense economic, social and environmental challenges, and I have seen first-hand how capital markets can be one of our most effective levers of change.”
Boyle is also the chair of the Long-term Investors in People’s Health programme, a $7trn (£5.8trn) global alliance of institutional investors.
Comments